Idera (IDRA) delivered earnings and revenue surprises of 26.25% and -9.44%, respectively, for the quarter ended June 2018. Do the…
The following instruments on XETRA do have their last trading day on 30.07.2018
Die folgenden Instrumente in XETRA haben ihren letzten…
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME …
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Idera Pharmaceuticals (NASDAQ:IDRA) today announced it would focus its efforts on bringing its cancer drug tilsotolimod (IMO-2125) to market following…
From a scuttled merger to tariff troubles, see why shares of these three companies fell hard today....…
Shares plunge after its proposed merger is called off. Heres what investors need to know....…
BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) has called it quits on its previously announced plan to merge with Idera Pharmaceuticals Inc (NASDAQ:IDRA) and…
Um den gesamten Artikel unter feedproxy.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Heres a roundup of top developments in the biotech space over the last 24 hours.
Scaling the Peaks
(Stocks hitting 52-week highs…
BioCryst Pharmaceuticals has failed to get approval from the stockholders for its merger deal with Idera Pharmaceuticals....…
BioCryst Pharmaceuticals has failed to get approval from the stockholders for its merger deal with Idera Pharmaceuticals....…
Todays Daily Dose brings you news about SCYNEXIS Dove study results; termination of the merger agreement between Idera and BioCryst…
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
GREENWICH, Conn., June 20, 2018 /PRNewswire/ -- Great Point Partners, LLC ("GPP") today submitted a letter to the Board of…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Shares of Idera (IDRA) decline following the failure of a phase II study of its pipeline candidate, IMO-8400, on adult…
Idera Pharmaceuticals Inc (NASDAQ:IDRA) shares sunk following the release of disappointing Phase 2 trial results. The biopharmas drug IMO-8400…
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
The company released preliminary data from an important phase 1/2 study....…
April 10 (Reuters) - Idera Pharmaceuticals Inc - New
Clinical Data On Ideras Imo :...…
* IDERA PHARMACEUTICALS FILES DEFINITIVE PROXY STATEMENT IN
CONNECTION WITH PENDING MERGER WITH BIOCRYST PHARMACEUTICALS...…
* BIOCRYST PHARMACEUTICALS FILES DEFINITIVE PROXY STATEMENT
IN
CONNECTION WITH PENDING MERGER WITH IDERA PHARMACEUTICALS...…
* IDERA PHARMACEUTICALS REPORTS FOURTH QUARTER AND YEAR END
2017
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
* IDERA PHARMACEUTICALS ANNOUNCES LAUNCH OF GLOBAL PHASE 3
TRIAL
EVALUATING IMO-2125 IN COMBINATION WITH IPILIMUMAB FOR THE
TREATMENT OF ANTI-PD-1 REFRACTORY MELANOMA…
NEW YORK, Mar. 1, 2018 /PRNewswire/ -- WallStEquities.com strives to bring the best free research to the investment community. …
* GREAT POINT PARTNERS LLC OPPOSES THE BIOCRYST
PHARMACEUTICAL
PROPOSED MERGER WITH IDERA PHARMACEUTICALS, INC....…
GREENWICH, Conn., Feb. 16, 2018 /PRNewswire/ -- Great Point Partners, LLC ("GPP") today submitted a letter to the Board of…
The announced merger of Idera Pharmaceuticals Inc. (NASDAQ:IDRA) and BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) will create a "new rare-disease powerhouse, analysts…
The announced merger of Idera Pharmaceuticals Inc. (NASDAQ:IDRA) and BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) will create a "new rare-disease powerhouse, analysts…
Shares of BioCryst Pharmaceuticals (BCRX) and Idera Pharmaceuticals (IDRA) plunge following the announcement of their merger....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Find out which company announced a merger....…
NEW YORK, Jan. 22, 2018 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique…
Is this a merger out of weakness and necessity? Wall Street might think so....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING…
BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) and Idera Pharmaceuticals Inc (NASDAQ:IDRA) are set to merge with the newly expanded company aiming to…
* BIOCRYST PHARMACEUTICALS AND IDERA PHARMACEUTICALS
ANNOUNCE
MERGER TO COMBINE CAPABILITIES TO SERVE MORE PATIENTS WITH RARE
DISEASES...…
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME …
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
* IDERA PHARMACEUTICALS - ANTICIPATES CURRENT CASH POSITION
CAPABLE OF FUNDING OPERATIONS INTO Q2 2019
Source text for Eikon:
Further company coverage:...…
Das Unternehmen Ranorex soll schon bisher zu etwas mehr als der Hälfte der Idera gehört haben. Dahinter stehen zwei Investorengruppen…
Idera-Tochter Gurock nun 100-Prozent-Eigentümer...…
Investors may want to put Idera Pharmaceuticals, Yamana Gold, and Ekso Bionics on their watchlists....…
NEW YORK, Dec. 1, 2017 /PRNewswire/ -- In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com…